Indivior Backs FY View, Warns of Generic Rival Hit; Shares Fall

Indivior Backs FY View, Warns of Generic Rival Hit; Shares Fall

Shares of drugmaker Indivior Plc fell as much as 10 percent on Wednesday, a day after the company lost a legal battle that will allow an Indian generic rival to sell a copycat version of its blockbuster film-based opioid addiction treatment.

Read More…